Keurig Dr Pepper vs Constellation Brands
커피 시스템과 탄산음료 브랜드를 보유한 음료 그룹 vs 북미를 대표하는 프리미엄 주류 제조업체. 9월 2026에 내 포트폴리오에 더 잘 맞는 종목은 무엇일까요? 아래에서 쉽게 설명합니다.
Keurig Dr Pepper sells beverages through grocery, convenience stores, and its at-home pod brewing system, backed by a wide portfolio of owned and licensed brands that gives it shelf presence across categories from coffee to juice to soda, while Constellation Brands concentrates on premium beer, wine, and spirits with a flagship position in imported Mexican beer brands like Modelo and Corona. Both generate substantial free cash flow and have demonstrated consistent dividend growth backed by consumer loyalty to their core brands. Keurig Dr Pepper vs Constellation Brands compares a diversified beverage platform with multi-category reach against a focused premium alcohol portfolio banking on continued trade-up in the beer aisle.
Keurig Dr Pepper sells beverages through grocery, convenience stores, and its at-home pod brewing system, backed by a wide portfolio of owned and licensed brands that gives it shelf presence across ca...
주가 변동 요인
Keurig Dr Pepper gains attention as its split plan and portfolio cleanup keep the turnaround story alive.
- Keurig Dr Pepper signaled progress on its restructuring plan, saying it is integrating JDE Peet’s while preparing for a 2027 separation into two companies, a setup investors often view as a potential catalyst for unlocking value.
- Management reaffirmed 2026 revenue guidance and low double-digit constant-currency EPS growth, which suggests the core beverage business is still expanding even as the company takes on major portfolio changes.
- The recently announced Chobani asset and equity sale adds cash and simplifies the portfolio, reinforcing the market’s focus on deleveraging and execution rather than near-term disruption.
STZ is moving as investors weigh balance-sheet discipline against margin pressure and a tougher consumer backdrop.
- Constellation Brands announced an early redemption of $600 million of 4.350% senior notes due 2027, a move that points to active balance-sheet management rather than a change in core operating momentum.
- Management used its Barclays Global Consumer Conference appearance to emphasize a shift toward a more operator-focused model, signaling tighter execution as it works through a mixed consumer backdrop.
- Recent commentary also flagged margin pressure from higher transportation and commodity costs, keeping attention on how much profit the business can protect in the second half of the year.
Keurig Dr Pepper gains attention as its split plan and portfolio cleanup keep the turnaround story alive.
- Keurig Dr Pepper signaled progress on its restructuring plan, saying it is integrating JDE Peet’s while preparing for a 2027 separation into two companies, a setup investors often view as a potential catalyst for unlocking value.
- Management reaffirmed 2026 revenue guidance and low double-digit constant-currency EPS growth, which suggests the core beverage business is still expanding even as the company takes on major portfolio changes.
- The recently announced Chobani asset and equity sale adds cash and simplifies the portfolio, reinforcing the market’s focus on deleveraging and execution rather than near-term disruption.
STZ is moving as investors weigh balance-sheet discipline against margin pressure and a tougher consumer backdrop.
- Constellation Brands announced an early redemption of $600 million of 4.350% senior notes due 2027, a move that points to active balance-sheet management rather than a change in core operating momentum.
- Management used its Barclays Global Consumer Conference appearance to emphasize a shift toward a more operator-focused model, signaling tighter execution as it works through a mixed consumer backdrop.
- Recent commentary also flagged margin pressure from higher transportation and commodity costs, keeping attention on how much profit the business can protect in the second half of the year.
투자 분석
장점
- Keurig Dr Pepper reported strong Q3 2025 results with a 10.7% year-over-year net sales growth, driven by robust U.S. Refreshment Beverages and improving coffee segment trends.
- The company raised its full-year net sales outlook while reaffirming adjusted EPS guidance, supported by disciplined inflation offset actions and strong innovation.
- Keurig Dr Pepper holds a significant market position with #1 North American share in single-serve pods and is executing strategic transformation including the JDE Peet’s acquisition.
고려 사항
- The company’s large scale limits its growth potential compared to smaller competitors, reflected in a below-average 5.9% annual revenue increase over the last three years.
- Operating margins have declined recently with rising day-to-day expenses outpacing revenue growth, indicating pressure on profitability.
- Below-average returns on capital suggest challenges in finding attractive investment opportunities to drive future growth.
장점
- Constellation Brands is a leading player in premium beverages with a strong portfolio including beer, wine, and spirits, supporting diversified revenue streams.
- The company benefits from established international distribution networks and strong brand recognition in key markets.
- Continued innovation and premiumisation trends in alcoholic beverages provide growth catalysts for Constellation Brands.
고려 사항
- Constellation Brands faces macroeconomic headwinds including inflationary pressures and changing consumer preferences that could impact demand.
- Exposure to regulatory and excise tax changes in alcoholic beverages markets adds risk to profitability and operational costs.
- High dependence on certain flagship brands and beer segment sensitivity to economic cycles present execution risks.
Keurig Dr Pepper(KDP) 다음 실적 발표일
Keurig Dr Pepper’s next earnings date is currently expected on October 26, 2026. The report should cover third-quarter 2026 results. This timing follows the company’s typical late-October pattern for its Q3 release.
Constellation Brands(STZ) 다음 실적 발표일
The next earnings date for STZ is expected on October 5, 2026, based on the company’s historical reporting pattern. That release should cover fiscal Q2 2027 results, reflecting the quarter ended August 31, 2026. This date is an estimate unless Constellation Brands confirms it in an official announcement.
Keurig Dr Pepper(KDP) 다음 실적 발표일
Keurig Dr Pepper’s next earnings date is currently expected on October 26, 2026. The report should cover third-quarter 2026 results. This timing follows the company’s typical late-October pattern for its Q3 release.
Constellation Brands(STZ) 다음 실적 발표일
The next earnings date for STZ is expected on October 5, 2026, based on the company’s historical reporting pattern. That release should cover fiscal Q2 2027 results, reflecting the quarter ended August 31, 2026. This date is an estimate unless Constellation Brands confirms it in an official announcement.
Nemo에서 KDP 또는 STZ 매수하기
수수료 무료
주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.
신뢰할 수 있는 규제 기관 인가
2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.
현금 예치금 6% 이자
투자하지 않은 현금에 연 6%(AER) 이자를 매일 지급합니다.
